Phase 2 Study of NV-5138 in Adults With Treatment Resistant Depression

Clinical trial NCT05066672 · COMPLETED

Trial details

NCT number: NCT05066672
Sponsor: Navitor Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Treatment Resistant Depression

Start date: 2022-01-18
Primary completion: 2025-01-21
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.